Health News (Reuters)

Reports of side effects with cosmetics increasing

(Reuters Health) - Reports of adverse events associated with cosmetics and personal care products sold in the U.S. more than doubled last year, due in large part to complaints about WEN by Chaz Dean Cleansing Conditioners, a new study suggests.

U.S. Senate Republicans to issue revised health bill to win support: aide

WASHINGTON (Reuters) - U.S. Senate Republicans plan to issue a revised version of their healthcare bill on Monday, according to a Republican Senate aide, as the chamber's leaders scrambled to get legislation passed ahead of a July 4 holiday recess starting on Friday.

Medicaid cuts linked to later breast cancer diagnosis

(Reuters Health) - More women may be diagnosed with advanced breast cancer and suffer treatment delays when Medicaid cutbacks eliminate coverage for many adults with low-income jobs, a study in Tennessee suggests.

Sexual equality in medical research long overdue, study finds

LONDON (Reuters) - Research labs may be short-changing women by ignoring differences between male and female animals in experiments to discover new drugs, suggesting sexual equality in scientific studies is overdue, researchers said on Monday.

EU tests limits of drug pricing freedom in landmark probe

BRUSSELS/LONDON (Reuters) - The first ever EU antitrust probe into excessive drug pricing is taking the European pharmaceuticals industry into uncharted territory, unnerving some companies and lawyers worried about the reach of market intervention.

Rubbish piles raise health fears in strike-hit Greece

ATHENS (Reuters) - Sacks of rubbish and rotting vegetables piled high on the pavements of Athens' port of Piraeus on Monday - signs of a mounting labor dispute fast turning into a public health crisis.

'Pharma bro' Martin Shkreli heads into fraud trial

NEW YORK (Reuters) - Martin Shkreli, the pharmaceutical entrepreneur vilified as the "pharma bro" for raising the price of a life-saving drug by 5,000 percent, will go on trial on Monday for what U.S. prosecutors called a Ponzi-like scheme at his former hedge fund and a drug company he once ran.

New Roche haemophilia drug prevents bleeds but questions remain

ZURICH (Reuters) - Roche's investigational haemophilia drug emicizumab cut the bleed rate by 87 percent in patients with resistance to standard therapy compared with those who received another treatment, the Swiss company said on Monday.

South Africa bans sale of live hens to contain bird flu

CAPE TOWN (Reuters) - South Africa has banned the sale of live hens throughout the country in a bid to control an outbreak of highly contagious H5N8 bird flu, but no humans have been affected, the government said on Monday.

USDA finds abscesses, unidentified material in raw Brazil beef: USDA

CHICAGO (Reuters) - The U.S. Department of Agriculture has found repeated import violations in raw Brazilian beef, including abscesses and unidentified foreign material, a top agency official said, explaining reasons for a U.S. ban on imports of fresh Brazilian beef.

Health insurers says Senate bill's Medicaid cuts to hurt states

NEW YORK (Reuters) - Health insurers are concerned about the U.S. Senate's plans to cut the Medicaid program for the poor and the impact such a move would have on state governments, the industry's largest lobbyist said on Friday.

Portola shares soar after FDA approves clot preventing drug

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery.

Pages